STAGE III OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7
Clinical trials for STAGE III OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack on HPV-Linked throat cancer
Disease control OngoingThis study is testing whether combining two immunotherapy drugs (ipilimumab and nivolumab) with a targeted course of radiation is safe and effective for treating advanced throat cancer caused by HPV. The goal is to help the body's immune system better recognize and attack the can…
Matched conditions: STAGE III OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 04, 2026 00:50 UTC
-
Head-to-Head cancer radiation trial: protons vs. photons
Disease control OngoingThis study aims to find out if a newer type of radiation called proton beam therapy is better than standard photon therapy for treating throat cancer. It will compare how well each treatment controls the cancer and, importantly, which one causes fewer severe side effects. About 4…
Matched conditions: STAGE III OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Scientists test new weapon to boost cancer treatment
Disease control OngoingThis early-stage study is testing whether adding an experimental drug called berzosertib to standard chemotherapy (cisplatin) and radiation can better treat advanced head and neck cancer. The main goals are to find the safest and most effective dose of this new combination and to…
Matched conditions: STAGE III OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC